CSPR OVERTAKE: Sempra Q2 2026 Results Drive Market Focus

• Sempra reported a significant surge in Q2 2026 net income, reaching $942 million compared to $519 million in the prior year period, driven by increased electric utility revenues and improved operational efficiency.
• Manulife Financial showcased robust growth in its Asia segment, with new business CSM rising to $777 million in Q2 2026, reflecting strong demand for life insurance products in key markets like Hong Kong and Japan.
• The Real Brokerage Inc. announced its Q2 2026 financial results, emphasizing importance of SEC filings for investors reviewing proposed transactions and regulatory disclosures.
• Ensysce Biosciences Inc. completed the acquisition of Cy Biopharma and secured up to $77 million in private financing, signaling strategic expansion in the biotech sector.
• Seven Greens Solar Systems expanded its rooftop solar installations for the South Central Railway in India, utilizing non-penetrative fixing technology to support sustainable infrastructure goals.

Sempra delivered strong second-quarter 2026 results, highlighting significant year-over-year improvements in profitability and operational efficiency. Diluted earnings per share (EPS) reached $1.21, a substantial increase from $0.71 in the same period of 2025. On a year-to-date basis, diluted EPS stood at $2.80, up from $2.09 in 2025, indicating sustained momentum throughout the first half of the year.

Total revenues for the quarter were $2,997 million, nearly flat compared to $3,000 million in Q2 2025. However, the composition of revenue shifted favorably, with electric revenues increasing to $1,158 million from $1,031 million. Natural gas revenues declined slightly to $1,364 million from $1,470 million, while energy-related businesses contributed $475 million in revenue.

Profitability metrics showed marked improvement, with net income surging to $942 million, compared to $519 million in the prior year period. This growth was supported by a reduction in the cost of natural gas to $(63) million from $(183) million and better-than-expected operation and maintenance expenses. Interest expense remained a significant drag on earnings, rising to $(430) million from $(359) million, but was offset by higher equity earnings of $547 million compared to $393 million in the prior year.

Why Did Sempra's Net Income Surge in Q2 2026?

Sempra attributed the earnings growth to higher electric utility revenues, increased equity earnings from subsidiaries, and lower cost of natural gas. The company reported diluted earnings per share of $1.21, up from $0.71 in the prior year period, underscoring the underlying strength of its utility and energy businesses. Sempra Adjusted Earnings and Adjusted EPS are non-GAAP financial measures that further highlight the operational resilience of the company.

The company continues to navigate a complex regulatory environment, with clear distinctions noted between its infrastructure partners, Texas utilities, and California utilities regulated by the CPUC. Sempra emphasized that this press release contains forward-looking statements based on assumptions about the future, which involve risks and uncertainties and are not guarantees. Investors are directed to sempra.com and investor.sempra.com/corporate-updates for important information and to monitor all channels, including SEC filings and public conference calls, for material information.

How Is Manulife Performing in Asian Markets?

Manulife Financial Corporation reported its second-quarter 2026 results, with a focus on the growth of new business Contractual Service Margin (CSM) across its international segments. In the Asia segment, new business CSM for the quarter was $777 million, showing resilience compared to $663 million in Q2 2025. Year-to-date CSM for Asia reached $1,579 million, up from $1,378 million in the prior year, suggesting continued momentum in the region.

Hong Kong remained a key contributor, with quarterly new business CSM of $322 million, up from $286 million in Q2 2025. Japan also showed strong performance, with quarterly CSM of $122 million, significantly higher than the $74 million recorded in Q2 2025. Mainland China contributed $66 million in quarterly new business CSM, while Singapore posted $228 million. The 'Other' category contributed $39 million, indicating a strategic success in capturing value from high-margin markets in Asia.

What Are the Latest Regulatory Updates for Real Brokerage and Ensysce?

The Real Brokerage Inc. (REAX) announced its financial results for the second quarter of 2026 as part of its regulatory disclosure process. Investors and security holders are urged to carefully read the Registration Statement, the REAL Management Information Circular, and the Proxy Statement/Prospectus filed with the SEC and Canadian securities regulators. These documents contain important information about the proposed transaction and related matters, with free copies available on the SEC’s website, SEDAR+, or through the company’s investor relations contacts.

Ensysce Biosciences Inc. announced the acquisition of Cy Biopharma and up to $77 million in private financing. The company indicated that stockholders can obtain free copies of the proxy statement and relevant documents through the SEC website. Participants in the solicitation, including Ensysce, Cy Biopharma, and their directors and officers, may be deemed participants in the proxy solicitation, with further details contained in the proxy statement and other materials filed with the SEC.

How Is Seven Greens Solar Systems Supporting Sustainable Infrastructure?

Seven Greens Solar Systems Private Limited has secured repeat orders from South Central Railway for major solar installations across the Secunderabad division. The company's approach focuses on structural integrity and efficiency, utilizing specialized non-penetrative sheet fixing that avoids drilling into metal roof sheets, thereby preserving the integrity of Cover Over Platforms (COP) and railway sheds. Key infrastructure projects include a 1,000 kWp installation at the Cherlapalli Shed and a 200 kWp system at Ramagundam Shed.

Additional high-capacity deployments are underway at the Mancherial Car Park Canopy (100 kWp), Khammam (100 kWp), and Bidar (100 kWp). Smaller installations, ranging from 55 kWp to 65 kWp, are also being implemented at Bellampalli, Lingampalli, and Parli. The company is also deploying Building Integrated Photovoltaics (BIPV), highlighted by a 100 kWp system at Kazipet station, aligning with broader industry trends toward sustainable engineering for institutional and commercial infrastructure.

Costamare Bulkers Holdings Ltd (CMDB) reported Q1 2026 net income of $9.9 million, with adjusted net income reaching $12.4 million. The company achieved a net cash positive position of $127 million against $640 million in debt, following the transfer of its legacy trading portfolio to Cargill. A key strategic move was the successful transfer of the majority of its legacy trading portfolio to Cargill, significantly derisking the balance sheet and reducing financial exposure.

The CEO, Zikos, emphasized the company's strategic positioning for countercyclical growth in a low asset value environment. New vessels are being chartered at profitable rates, reflecting strong market demand, and a second newbuilding Kamsarmax vessel delivery is anticipated by year-end. The legacy trading transfer is expected to be completed by the end of 2026, further stabilizing the company's financial position.